Bipolarity presenting as anxiety disorders

Primary Psychiatry

Volumn 11, Issue 10, 2004, Pages 31-35

  Perugi, Giulio ^a,b   Toni, Cristina ^b  

^a UNIVERSITY OF PISA   (Italy)

^b Institute of Behavioral Science   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; GABAPENTIN; MOOD STABILIZER; NEUROLEPTIC AGENT; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG; VALPROIC ACID;

ALCOHOL ABUSE; ANXIETY DISORDER; BIPOLAR DISORDER; CLINICAL FEATURE; CLINICAL STUDY; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC ERROR; DRUG EFFICACY; HUMAN; HYPOMANIA; MAJOR DEPRESSION; MANIA; MOOD DISORDER; MORBIDITY; OBSESSIVE COMPULSIVE DISORDER; PANIC; PATIENT MONITORING; PROSPECTIVE STUDY; REVIEW; SOCIAL PHOBIA; SUBSTANCE ABUSE;

EID: 8444235086     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8-19.
2. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord. 1998;50(2-3):143-151.
3. Chen YW, Dilsaver SC. Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders. Psychiatry Res. 1995;59(1-2):57-64.
4. Perugi G, Toni C, Akiskal HS. Anxious-bipolar Comorbidity Diagnostic and treatment challenges. Psychiatr Clin North Am. 1999;22(3):565-583.
5. Himmelhoch JM. Social anxiety, hypomania and the bipolar spectrum: data, theory and clinical issues. J Affect Disord. 1998;50(2-3):203-213.
6. Angst J, Dobler-Mikola A. The Zurich Study. VI. A continuum from depression to anxiety disorders? Eur Arch Psychiatry Neurol Sci. 1985;235(3):179-186.
7. Stavrakaki C, Vargo B. The relationship of anxiety and depression: a review of the literature. Br J Psychiatry. 1986;149:7-16.
8. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
9. Savino M, Perugi G, Simonini E, Soriani A, Cassano GB, Akiskal HS. Affective comorbidity in panic disorder: is there a bipolar connection? J Affect Disord. 1993;28(3):155-163.
10. Shoaib AM, Dilsaver SC. Panic disorder in subjects with pure mania and depressive mania. Anxiety. 1994-1995;1(6):302-304.
11. Rihmer Z, Barsi J, Belso N, Pestality P, Gyorgy S. Antidepressant-induced hypomania in obsessive-compulsive disorder. Int Clin Psychopharmacol. 1996;11(3):203-205.
12. Kruger S, Cooke RG, Hasey GM, Jorna T, Persad E. Comorbidity of obsessive compulsive disorder in bipolar disorder. J Affect Disord. 1995;34(2):117-120.
13. Perugi G, Akiskal HS, Pfanner C, et al. The clinical impact of bipolar and unipolar affective comorbidity on obsessive-compulsive disorder. J Affect Disord. 1997;46(1):15-23.
14. Perugi G, Akiskal HS, Ramacciotti S, et al. Depressive comorbidity of panic, social phobic, and obsessive-compulsive disorders re-examined: is there a bipolar II connection? J Psychiatr Res. 1999;33(1):53-61.
15. McElroy SL, Altshuler LL, Suppes T, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry. 2001;158(3):420-426.
16. Feske U, Frank E, Mallinger AG, et al. Anxiety as a correlate of response to the acute treatment of bipolar I disorder. Am J Psychiatry. 2000;157(6):956-962.
17. Dunner DL, Tay LK. Diagnostic reliability of the history of hypomania in bipolar II patients and patients with major depression. Compr Psychiatry. 1993;34(5):303-307.
18. Manning JS, Haykal RF, Connor PD, Akiskal HS. On the nature of depressive and anxious states in a family practice setting: the high prevalence of bipolar II and related disorders in a cohort followed longitudinally. Compr Psychiatry. 1997;38(2):102-108.
19. Benazzi F. Prevalence of bipolar II disorder in outpatient depression: a 203-case study in private practice. J Affect Disord. 1997;43(2):163-166.
20. Hantouche EG, Akiskal HS, Lancrenon S, et al. Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP). J Affect Disord. 1998;50(2-3):163-173.
21. Akiskal HS, Djenderedjian AM, Rosenthal RH, Khani MK. Cyclothymic disorder: validating criteria for inclusion in the bipolar affective group. Am J Psychiatry. 1977;134(11):1227-1233.
22. International Statistical Classification of Diseases and Related Health Problems. 10th rev. Geneva, Switzerland: World Health Organization, 1992.
23. Perugi G, Akiskal HS. The soft bipolar spectrum redefined: focus on the cyclothymic, anxious-sensitive, impulse-dyscontrol, and binge-eating connection in bipolar II and related conditions. Psychiatr Clin North Am. 2002;25(4):713-737.
24. Perugi G, Akiskal HS, Toni C, Simonini E, Gemignani A. The temporal relationship between anxiety disorders and (hypo)mania: a retrospective examination of 63 panic, social phobic and obsessive-compulsive patients with comorbid bipolar disorder. J Affect Disord. 2001;67(1-3):199-206.
25. MacKinnon DF, McMahon FJ, Simpson SG, McInnis MG, DePaulo JR. Panic disorder with familial bipolar disorder. Biol Psychiatry. 1997;42(2):90-95.
26. Perugi G, Akiskal HS, Gemignani A, et al. Episodic course in obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci. 1998;248(5):240-244.
27. Dilsaver SC, White K. Affective disorders and associated psychopathology: a family history study. J Clin Psychiatry. 1986;47(4):162-169.
28. Klein DN, Depue RA, Slater JF. Inventory-identification of cyclothymia. IX. Validation in offspring of bipolar I patients. Arch Gen Psychiatry. 1986;43(5):441-445.
29. Coryell W. Obsessive-compulsive disorder and primary unipolar depression. Comparisons of background, family history, course, and mortality. J Nerv Ment Dis. 1981;169(4):220-224.
30. Perugi G, Frare F, Madaro D, Maremmani I, Akiskal HS. Alcohol abuse in social phobic patients: is there a bipolar connection? J Affect Disord. 2002;68(1):33-39.
31. Himle JA, Abelson JL, Haghightgou H, Hill EM, Nesse RM, Curtis GC. Effect of alcohol on social phobic anxiety. Am J Psychiatry. 1999;156(8):1237-1243.
32. Young LT, Cooke RG, Robb JC, Levitt AJ, Joffe RT. Anxious and non-anxious bipolar disorder. J Affect Disord. 1993;29(1):49-52.
33. Swann AC, Bowden CL, Morris D, et al. Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry. 1997;54(1);37-42.
34. Lum M, Fontaine R, Elie R, et al. Divalproex sodium's anti-panic effect in panic disorder: a placebo-controlled study. Biol Psychiatry. 1990;27:164A-165A.
35. Calabrese JR, Delucchi GA. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiatry. 1990;147(4):431-434.
36. Deltito JA. Valproate pretreatment for the difficult-to-treat patient with OCD. J Clin Psychiatry. 1994;55(11):500.
37. Cora-Locatelli G, Greenberg BD, Martin JD, Murphy DL. Valproate monotherapy in an SRI-intolerant OCD patient. J Clin Psychiatry. 1998;59(2):82.
38. Uhde TW, Stein MB, Post RM. Lack of efficacy of carbamazepine in the treatment of panic disorder. Am J Psychiatry. 1988;145(9):1104-1109.
39. Koopowitz LF, Berk M. Response of obsessive compulsive disorder to carbamazepine in two patients with comorbid epilepsy. Ann Clin Psychiatry. 1997;9(3):171-173.
40. Joffe RT, Swinson RP. Carbamazepine in obsessive-compulsive disorder. Biol Psychiatry. 1987;22(9):1169-1171.
41. Pande AC, Davidson JR, Jefferson JW, Jet al. Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol 1999;19(4):341-348.
42. Pollack MH, Matthews J, Scott EL. Gabapentin as a potential treatment for anxiety disorders. Am J Psychiatry. 1998;155(7):992-993.
43. Perugi G, Toni C, Frare F, et al. Effectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidity? J Gin Psychopharmacol. 2002;22(6):584-591.
44. Carta MG, Hardoy MC, Hardoy MJ, Grunze H, Carpiniello B. The clinical use of gabapentin in bipolar spectrum disorders. J Affect Disord. 2003;75(1):83-91.
45. Spina E, Perugi G. Antiepileptic drugs: indications other than epilepsy. Epileptic Disord. 2004;6(2):57-75.
46. Pande AC, Pollack MH, Crockatt J, et al. Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol. 2000;20(4):467-471.
47. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed rev. Washington, DC: American Psychiatric Association; 1987.
48. Steiner W. Fluoxetine-induced mania in a patient with obsessive-compulsive disorder. Am J Psychiatry. 1991;148(10):1403-1404.
49. Sholomskas AJ. Mania in a panic disorder patient treated with fluoxetine. Am J Psychiatry. 1990;147(8):1090-1091.
50. Jann MW, Bitar AH, Rao A. Lithium prophylaxis of tricyclic- antidepressant-induced mania in bipolar patients. Am J Psychiatry. 1982;139(5):683-684.
51. Kane JM, Quitkin FM, Rifkin A, Ramos-Lorenzi JR, Nayak DD, Howard A. Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison. Arch Gen Psychiatry. 1982;39(9):1065-1069.
52. Hurowitz GI, Liebowitz MR. Antidepressant-induced rapid cycling: six case reports. J Clin Psychopharmacol. 1993;13(1):52-56.
53. Landry P, Roy L. Withdrawal hypomania associated with paroxetine. J Clin Psychopharmacol. 1997;17(1):60-61.
54. McIntyre R, Katzman M. The role of atypical antipsychotics in bipolar depression and anxiety disorders. Bipolar Disord. 2003;5(suppl 2):20-35.
55. Baker RW, Chengappa KN, Baird JW, Steingard S, Christ MA, Schooler NR. Emergence of obsessive compulsive symptoms during treatment with clozapine. J Clin Psychiatry. 1992;53(12):439-442.
56. de Haan L, Beuk N, Hoogenboom B, Dingemans P, Linszen D. Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders. J Clin Psychiatry. 2002;63(2):104-107.